Valuation: 4DMedical Limited

Market Cap 2.18B 1.53B 1.33B 1.24B 1.14B 2.14B 146B 14.57B 5.72B 72.61B 5.74B 5.61B 243B P/E 2026 *
-11.4x
P/E 2027 * -57.8x
Enterprise Value 1.91B 1.34B 1.17B 1.09B 997M 1.88B 128B 12.8B 5.02B 63.79B 5.04B 4.93B 214B EV / Sales 2026 *
229x
EV / Sales 2027 * 87.6x
Free-Float
93.57%
Yield 2026 *
-
Yield 2027 * -
1 day+13.08%
1 week+16.72%
1 month-10.15%
3 months-9.70%
6 months+14.51%
Current year-7.63%
1 week 3.13
Extreme 3.13
3.65
1 month 3.06
Extreme 3.06
4.61
Current year 2.95
Extreme 2.95
7.55
1 year 0.3
Extreme 0.305
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 30/11/2012
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 31/03/2023
Director TitleAgeSince
Director/Board Member - 30/11/2012
Chairman - 01/11/2023
Director/Board Member - 30/09/2017
Date Insider Type Main position Quantity % Market Cap.
18/06/26 Buy

Chief Financial Officer

13,054 0.0022%
22/01/26 Sell

Chief Financial Officer

2,666,666 0.5078%
22/01/26 Sell

Founder

263,157 0.0501%
Change 5-day change 1-year change 3-year change Capi.($)
+13.08%+16.72%+1,090.16%+433.82% 1.53B
-0.43%+1.06%+24.03%+5.21% 212B
-0.61%+1.82%-1.07%-23.54% 137B
+0.10%+4.69%-26.86%+9.07% 125B
+1.59%+5.60%-55.67%-9.94% 69.46B
-0.98%+4.16%+8.50%+4.90% 49.56B
-0.91%+5.13%-20.61%-29.50% 47.2B
-0.25%-0.14%+21.91%+12.97% 39.08B
-0.79%+0.70%+29.97%+37.50% 37.05B
+0.00%+5.67%+116.67%+8.35% 30.97B
Average +1.08%+4.50%+118.70%+44.89% 74.91B
Weighted average by Cap. -0.22%+2.80%+5.91%-0.01%

Financials

2026 *2027 *
Net sales 8.34M 5.85M 5.09M 4.74M 4.35M 8.21M 559M 55.84M 21.91M 278M 21.99M 21.5M 933M 22.25M 15.62M 13.58M 12.64M 11.6M 21.91M 1.49B 149M 58.47M 742M 58.67M 57.38M 2.49B
Net income -177M -124M -108M -101M -92.32M -174M -11.86B -1.19B -465M -5.91B -467M -456M -19.8B -37.1M -26.04M -22.64M -21.07M -19.34M -36.53M -2.49B -248M -97.47M -1.24B -97.8M -95.65M -4.15B
Net Debt -264M -186M -161M -150M -138M -260M -17.72B -1.77B -695M -8.82B -697M -682M -29.58B -228M -160M -139M -130M -119M -225M -15.3B -1.53B -600M -7.62B -602M -589M -25.54B
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
124
Date Price Change Volume
31/07/26 A$3.630 +13.08% 7,329,046
30/07/26 A$3.210 -1.53% 2,190,290
29/07/26 A$3.260 +0.31% 2,709,304
28/07/26 A$3.250 -0.91% 3,250,268
27/07/26 A$3.280 +5.47% 3,541,741
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.630AUD
Average target price
4.967AUD
Spread / Average Target
+36.82%

Quarterly revenue - Rate of surprise